scPharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Scpharmaceuticals

16/05/2022 14:32

* scPharmaceuticals Inc  SCPH.OQ  reported a quarterly
adjusted
loss of 28 cents​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 31 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * scPharmaceuticals Inc's reported EPS for the quarter was a
loss
of 28 cents​.
    * The mean earnings estimate of analysts had risen by
about 13.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * scPharmaceuticals Inc shares had fallen by 21.8% this
quarter and lost 11.6% so far this year.
    * The company reported a quarterly loss of $7.73 million.
    * Wall Street's median 12-month price target for
scPharmaceuticals
Inc is $11.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 16 at 01:32 p.m.  ​All
figures in US dollars unless otherwise stated